{
    "code": "02024011",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02024011",
    "time": "2024-03-21 21:03:15",
    "許可證字號": "衛署藥輸字第024011號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "",
    "有效日期": "118\/06\/11",
    "發證\/登錄日期": "93\/06\/11",
    "許可證\/登錄種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "第一等級醫療器材原許可證字號": "",
    "第一等級醫療器材新登錄字號": "",
    "通關簽審文件編號": "DHA00202401104",
    "中文品名": "威爾眸點眼液 0.5%",
    "英文品名": "VIGAMOX OPHTHALMIC SOLUTION 0.5%",
    "適應症": "治療下列微生物具感受性的菌株所引起的細菌性結膜炎。好氧性革蘭氏陽性菌：CORYNEBACTERIUM SPECIES、MICROCOCCUS LUTEUS、STAPHYLOCOCCUS AUREUS、STAPHYLOCOCCUS EPIDERMIDIS、STAPHYLOCOCCUS HAEMOLYTICUS、STAPHYLOCOCCUS HOMINIS、STAPHYLOCOCCUS WARNERI、STREPTOCOCCUS PNEUMONIAE、STREPTOCOCCUS VIRIDANS GROUP。好氧性革蘭氏陰性菌：ACINETOBACTER LWOFFII、HAEMOPHILUS INFLUENZAE、HAEMOPHILUS、PARAINFLUENZAE。其他：CHLAMYDIA TRACHOMATIS。對此細菌有效性的研究少於10各感染數。",
    "劑型": "472點眼液劑",
    "包裝": "100公撮以下塑膠瓶裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "06須由醫師處方使用",
    "管制藥品分類級別": "",
    "藥品分類": "",
    "監視期限": "",
    "主成分略述": "MOXIFLOXACIN HYDROCHLORIDE",
    "限制項目": "02輸　入 54依本署89、12、12衛署藥字第0890035812號公告事項九得免除國內進行臨床試驗之特殊醫療需要之新藥",
    "申請商名稱": "台灣諾華股份有限公司",
    "申請商地址": "台北市中山區民生東路三段2號8樓",
    "主製造廠": [
        {
            "製造廠名稱": "S.A. ALCON-COUVREUR N.V.",
            "製造廠廠址": "RIJKSWEG 14, 2870 PUURS, BELGIUM",
            "製造廠公司地址": "",
            "製造廠國別": "BELGIUM",
            "製程": ""
        }
    ],
    "次製造廠": [
        {
            "製造廠名稱": "NOVARTIS PHARMA AG",
            "製造廠廠址": "LICHTSTRASSE 35, CH-4056 BASEL, SWITZERLAND",
            "製造廠公司地址": "",
            "製造廠國別": "SWITZERLAND",
            "製程": "許可證持有者"
        }
    ],
    "CCC號列": "30042000916 人用醫藥製劑，含有其他抗生素者Medicaments, containing other antibiotics, for human use",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "0812700910",
            "成分名稱": "MOXIFLOXACIN HYDROCHLORIDE",
            "含量描述": "",
            "含量": "5.4500000000",
            "單位": "MG"
        }
    ],
    "藥物辨識詳細資料": {
        "外觀尺寸": "",
        "特殊劑型": "",
        "顏色": "",
        "特殊氣味": "",
        "刻痕": "",
        "形狀": "",
        "標記一": "",
        "標記二": ""
    },
    "藥物辨識外觀圖片": [
        {
            "title": "024011_VIGAMOX Ophthalmic Solution 0.5%-108-06-24(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02024011&Seq=001&Type=10"
        }
    ],
    "仿單外盒": [
        {
            "title": "附件6-3_Vigamox_仿單-110-11-24.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02024011&Seq=015&Type=9"
        },
        {
            "title": "附件6-2_Vigamox_標籤-110-11-24.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02024011&Seq=011&Type=8"
        },
        {
            "title": "附件6-1_Vigamox_外盒-110-11-24.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02024011&Seq=010&Type=8"
        }
    ]
}